ADLM Calls on Feds to Regulate AI in the Clinical Lab Sector
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
From - G2 Compliance Advisor
The OIG added four new items to its Work Plan this month, all of which have potential indirect effects on clinical labs involved in providing the…
From - National Intelligence Report
It has been nearly two years since Millennium went into Chapter 11 but the case continues to make news. After agreeing to…
From - G2 Compliance Advisor
It's official. Brushing aside fierce lab industry opposition, CMS has decided to go forward with its PAMA Clinical Laboratory Fee Schedule (CLFS) in 2018…
From - National Intelligence Report
While data breaches inside labs and other health care settings happen all the time, lawsuits for money damages by victims have been relatively unusual…
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
The approach of the holiday season signals the end of another year. Was this just another year in a long line of them for you in lab safety, or was it…
From - Laboratory Industry Report
With all of the PAMA commotion, CMS's publication of the 2018 Medicare Hospital and Ambulatory Surgical Outpatient Prospective Payment System (OPPS) final rule has…